FINE MAPPING OF MONOCLONAL-ANTIBODY EPITOPES ON HUMAN VONWILLEBRAND-FACTOR USING A RECOMBINANT PEPTIDE LIBRARY

被引:0
|
作者
GINSBURG, D
BOCKENSTEDT, PL
ALLEN, EA
FOX, DA
FOSTER, PA
RUGGERI, ZM
ZIMMERMAN, TS
MONTGOMERY, RR
BAHOU, WF
JOHNSON, TA
YANG, AY
机构
[1] UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, ANN ARBOR, MI 48104 USA
[2] UNIV MICHIGAN, SCH MED, DEPT INTERNAL MED, ANN ARBOR, MI 48104 USA
[3] BLOOD CTR SE WISCONSIN INC, MILWAUKEE, WI USA
[4] MED COLL WISCONSIN, MILWAUKEE, WI 53226 USA
[5] SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA
[6] SCRIPPS RES INST, COMM VASC BIOL, LA JOLLA, CA 92037 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A recombinant human von Willebrand factor (vWF) cDNA fragment library was constructed in lambda-gt11 for the localization of anti-vWF monoclonal antibody epitopes. Twelve of 21 monoclonal antibodies screened identified epitopes expressed in lambda-gt11 as beta-galactosidase fusion proteins. By sequence analysis, these antigenic determinants were localized to segments ranging from 17 to 105 amino acids in length. Four epitopes apparently shared by more than one antibody were identified, suggesting the presence of immuno-dominant epitopes within vWF. Monoclonal antibody C3, which blocks factor VIII (FVIII) binding to vWF, bound to the same epitope previously identified by a second monoclonal antibody which also blocks this function, suggesting that this region may be at or near the vWF/FVIII binding domain. Three antibodies recognize the same region within the vWF A2 repeat. Mutations near this region appear to be responsible for Type IIA von Willebrand's disease. The co-localization of these antibodies suggests that this domain might be exposed on the surface of vWF, consistent with its apparent increased sensitivity to plasma proteases.
引用
收藏
页码:166 / 171
页数:6
相关论文
共 50 条
  • [1] MULTIMER ANALYSIS OF VONWILLEBRAND-FACTOR USING MONOCLONAL-ANTIBODY
    RYU, T
    [J]. ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (08): : 1689 - 1696
  • [2] HUMAN FACTOR-VIII-C PURIFIED USING MONOCLONAL-ANTIBODY TO VONWILLEBRAND-FACTOR - INTRODUCTION
    LEVINE, PH
    [J]. SEMINARS IN HEMATOLOGY, 1988, 25 (02) : 1 - 2
  • [3] MONOCLONAL-ANTIBODY WITH PREFERENTIAL AFFINITY FOR LARGE MULTIMERS OF VONWILLEBRAND-FACTOR
    RYU, T
    NAKAYAMA, A
    OGUCHI, A
    KINOSHITA, T
    KAZAMA, M
    ABE, T
    [J]. THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 353 - 353
  • [4] MONOCLONAL-ANTIBODY PURIFICATION OF A 130-KD FRAGMENT OF VONWILLEBRAND-FACTOR THAT CONTAINS PLATELET BINDING EPITOPES
    MONTGOMERY, RR
    UNGER, JJ
    VOKAC, EA
    [J]. CIRCULATION, 1984, 70 (04) : 209 - 209
  • [5] ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR VONWILLEBRAND-FACTOR ANTIGEN USING A MONOCLONAL-ANTIBODY
    INOUE, K
    MAZDA, T
    TOBE, T
    TOMITA, M
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1986, 34 (06) : 2550 - 2554
  • [6] MAPPING OF FUNCTIONAL DOMAINS OF HUMAN VONWILLEBRAND-FACTOR USING MONOCLONAL-ANTIBODIES
    GIRMA, JP
    KALAFATIS, M
    PIETU, G
    LAVERGNE, JM
    EDGINGTON, TS
    MEYER, D
    [J]. THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 59 - 59
  • [7] A MONOCLONAL-ANTIBODY TO FACTOR-VIII INHIBITS VONWILLEBRAND-FACTOR BINDING AND THROMBIN CLEAVAGE
    PRECUP, JW
    KLINE, BC
    FASS, DN
    [J]. BLOOD, 1991, 77 (09) : 1929 - 1936
  • [8] PREVENTION OF OCCLUSIVE CORONARY-THROMBOSIS BY MONOCLONAL-ANTIBODY TO VONWILLEBRAND-FACTOR IN SWINE
    NICHOLS, TC
    BELLINGER, DA
    READ, MS
    REDDICK, RL
    BRINKHOUS, KM
    GRIGGS, TR
    LAMB, MA
    [J]. THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 9 - 9
  • [9] EFFECTS OF A MONOCLONAL-ANTIBODY TO HUMAN-PLATELET GLYCOPROTEIN I ON PLATELET - VONWILLEBRAND-FACTOR SUBENDOTHELIUM INTERACTIONS
    RUAN, C
    TOBELEM, G
    MCMICHAEL, A
    DROUET, L
    LEGRAND, Y
    CAEN, JP
    [J]. THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 98 - 98